Why the Catapult share price raced 15% higher today

The Catapult Group International Ltd (ASX:CAT) share price has rocketed 15% higher today. Here's why…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Catapult Group International Ltd (ASX: CAT) share price has been a strong performer on Thursday following the release of its half year results.

At the time of writing the sports analytics and wearables company's shares are up over 15% to 71.5 cents.

Why is the Catapult share price surging higher?

This morning Catapult released its half year results and revealed a 42% increase in revenue, and EBITDA loss of $1.4 million, and a net loss of $9.3 million. The latter was an improvement of 34% on its loss during the prior corresponding period. I suspect the market had been expecting far worse, causing a bit of a relief rally today.

Annual recurring revenue (ARR) increased 25% to $57.4 million thanks to a solid performance from its core Elite segment which delivered high growth subscription revenue, strong margins, and low churn. The majority of its core elite revenue is now associated with SaaS software subscriptions.

The Elite Wearables business achieved ARR growth of 32% to $27.6 million and revenue growth of 38% to $19.6 million. Customer churn was 3.5% for the period, down from 8.4% a year earlier.

The Elite Video business grew ARR by 18% to $29.1 million and revenue by 22% to $20.7 million. During the half Catapult continued developing its tactical analytics solution (Catapult Vision) for elite clients and closed its first sales. Management expects Catapult Vision to become a key part of the elite technology stack and will integrate the analytics from wearables into the video interface.

Things weren't quite as positive for the much-hyped Prosumer segment. Whilst it delivered unit sales growth of 2.1x, it was from a low base and well short of original expectations. However, the Catapult board believes the business has a lot of long term potential and is committed to driving "sustainable growth at a rate more consistent with current market maturity and off a significantly reduced expense base."

Looking ahead, the company has reaffirmed its FY 2019 guidance. It expects core Elite revenue growth of between 17% and 20%, underlying core EBITDA growth of between 37% and 63%, and ARR growth above 20%.

The company also provided an update its CEO search following the surprise resignation of Joe Powell earlier this month. A global search is underway and "the Board is confident of appointing a high-quality candidate who can continue to scale the Company and drive further innovation whilst delivering cashflow positivity in line with forecasts."

Should you invest?

Whilst I'm a big fan of Catapult's products, I'm not a fan of the company as an investment. Especially after its CEO quit unexpectedly earlier this month.

According to that announcement, Mr Powell agreed that now is the right time for a new CEO to lead Catapult through its next phase of growth.

It is worth pointing out that he had been at the company for a little under two years after being brought in from SEEK Limited (ASX: SEK). At the time, executive chairman, Dr Adir Shiffman, said that Mr Powell would be "a key driver of our next phase of growth."

Maybe this is the phase that finally delivers for investors, but I'm not overly confident it will be. As a result, I'll be avoiding its shares for the time being and focusing on other tech options such as Altium Limited (ASX: ALU) and Appen Ltd (ASX: APX).

Motley Fool contributor James Mickleboro owns shares of SEEK Limited. The Motley Fool Australia owns shares of and has recommended Catapult Group International Ltd. The Motley Fool Australia owns shares of Altium and Appen Ltd. The Motley Fool Australia has recommended SEEK Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

three men stand on a winner's podium with medals around their necks with their hands raised in triumph.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

A business person directs a pointed finger upwards on a rising arrow on a bar graph.
Share Gainers

3 ASX 200 stocks storming higher in this week's sinking market

Investors have sent these three ASX 200 stocks soaring this week. But why?

Read more »

Two smiling work colleagues discuss an investment at their office.
Share Gainers

Why 4DMedical, Develop Global, EOS, and Maas shares are racing higher today

These shares are ending the week on a high. But why?

Read more »

Six smiling health workers pose for a selfie.
Healthcare Shares

Up 657% in a year, 4DMedcial shares rocketing another 20% today on big US news

ASX investors can’t get enough of 4DMedical shares today. Let’s see why.

Read more »

A neon sign says 'Top Ten'.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX 200 broke its losing streak to inch higher today.

Read more »

Wife and husband with a laptop on a sofa over the moon at good news.
Consumer Staples & Discretionary Shares

Bapcor shares soar 12% on the appointment of a new CEO

The market’s strong reaction reflects a clear message: investors are ready for a reset.

Read more »

A young woman drinking coffee in a cafe smiles as she checks her phone.
Share Gainers

Why Bapcor, IDP Education, Netwealth, and Ora Banda shares are pushing higher today

These shares are catching the eye with solid gains on Thursday. But why are they rising?

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

This ASX stock is going parabolic, and I think it's still a buy

4DMedical shares are up nearly 500% in 2025, but improving revenue visibility suggests the growth story may not be over.

Read more »